SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Reaches New 1-Year High – Time to Buy?

by · The Markets Daily

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $71.62 and last traded at $71.61, with a volume of 6412 shares trading hands. The stock had previously closed at $70.98.

SPDR S&P Pharmaceuticals ETF Stock Performance

The firm has a market capitalization of $516.17 million, a price-to-earnings ratio of 14.28 and a beta of 0.58. The business has a fifty day moving average price of $66.59 and a 200 day moving average price of $60.05.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Large investors have recently modified their holdings of the company. Bank of America Corp DE lifted its stake in shares of SPDR S&P Pharmaceuticals ETF by 128.0% in the 1st quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock valued at $43,918,000 after purchasing an additional 455,802 shares in the last quarter. Wells Fargo & Company MN increased its position in SPDR S&P Pharmaceuticals ETF by 175.6% during the 4th quarter. Wells Fargo & Company MN now owns 207,229 shares of the company’s stock worth $11,607,000 after purchasing an additional 132,037 shares in the last quarter. Goldman Sachs Group Inc. increased its position in SPDR S&P Pharmaceuticals ETF by 96.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 119,929 shares of the company’s stock worth $5,253,000 after purchasing an additional 59,007 shares in the last quarter. Private Advisor Group LLC purchased a new position in SPDR S&P Pharmaceuticals ETF in the first quarter valued at approximately $3,017,000. Finally, BNP Paribas Financial Markets raised its holdings in SPDR S&P Pharmaceuticals ETF by 123.8% in the fourth quarter. BNP Paribas Financial Markets now owns 89,500 shares of the company’s stock valued at $5,013,000 after buying an additional 49,500 shares during the period.

About SPDR S&P Pharmaceuticals ETF

(Get Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More